Clinical studies recruiting near Woolloongabba

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Princess Alexandra Hospital · Pfizer · NCT06758401 Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
Phase 2 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06989359 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Princess Alexandra Hospital · Boehringer Ingelheim · NCT07355296 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Dr Heart Pty Ltd · Amgen · NCT07037433 A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
Phase 1 · Integrated Clinical Oncology Network (ICON) Pty Ltd · Myeloid Therapeutics · NCT06478693 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 ROADMAP Clinical Trial
Phase 4 · Princess Alexandra Hospital · University of Newcastle, Australia · NCT06771050 A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic So
Phase 1/Phase 2 · Princess Alexandra Hospital · Daiichi Sankyo · NCT06330064 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Princess Alexandra Hospital ( Site 2102) · Merck Sharp & Dohme LLC · NCT06623422 TACKLE-IT Trial - Treat Acute T Cell Rejection With Evidence and Confidence in Kidney Transplant Recipients
Phase 3 · Princess Alexandra Hospital · University of Sydney · NCT06474273 Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
Phase 2 · Princess Alexandra Hospital · Basking Biosciences, Inc. · NCT06226805 A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
Phase 1 · Princess Alexandra Hospital · Janssen Research & Development, LLC · NCT05818683 A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Phase 1 · Princess Alexandra Hospital Australia · Incyte Corporation · NCT07195916 A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson'
Phase 3 · Princess Alexandra Hospital · Hoffmann-La Roche · NCT07174310 Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial
Phase 3 · Princess Alexandra Hospital · Monash University · NCT05072314 A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Phase 3 · Princess Alexandra Hospital · Daiichi Sankyo · NCT06203210 Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Phase 3 · Princess Alexandra Hospital · Immunocore Ltd · NCT05549297 Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)
Phase 3 · Princess Alexandra Hospital · The University of Queensland · NCT04939935 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07517263 SNV1521 in Participants With Advanced Solid Tumors
Phase 1 · Princess Alexandra Hospital · Synnovation Therapeutics, Inc. · NCT06220864 A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
Phase 3 · Princess Alexandra Hospital · Basilea Pharmaceutica · NCT06925321 Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in
Phase 3 · Princess Alexandra Hospital ( Site 3002) · Merck Sharp & Dohme LLC · NCT03486873 A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
Phase 1/Phase 2 · Princess Alexandra Hospital · BeOne Medicines · NCT05006716 A Practice Change for Patients With Severe Chronic, Clinically Unexplained Gastrointestinal Symptoms
NA · Princess Alexandra Hospital · The University of Queensland · NCT05274854 A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants Wit
Phase 1/Phase 2 · Princess Alexandra Hospital ( Site 5300) · Merck Sharp & Dohme LLC · NCT06780137 Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Ch
Phase 2 · Princess Alexandra Hospital · Australasian Gastro-Intestinal Trials Group · NCT06441747 A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Dar
Phase 3 · Princess Alexandra Hospital · Janssen Research & Development, LLC · NCT05552222 A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compar
Phase 3 · Princess Alexandra Hospital · BeOne Medicines · NCT06943872 FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage
Phase 2 · Princess Alexandra Hospital · The George Institute · NCT06409364 TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidos
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07223203

Look up another city

Look up another condition